Investors’ outlook regarding the stock price performance over the year has been a mixed bag, with a range of optimism to pessimism depending on their perspective. The metric has seen a significant gain of 76.10% since the start of this calendar year. Looking back over the last six months, we can see a weaker performance of 27.38%. Over the past 30 days, the price of CRDF has fallen by 16.01%. And in the last five days, it has surged by 8.33%.
The current stock price for Cardiff Oncology Inc (CRDF) is $4.42. The stock experienced a significant increase during the last trading session, reaching $18.0 after opening at $4.42. It dipped to a low of $3.5 before ultimately closing at $4.12.
In terms of market performance, Cardiff Oncology Inc had a somewhat regular. The highest value for the stock in the past year was $5.64 on 12/17/24, while the lowest value was $2.01 on 08/05/24.
52-week price history of CRDF Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. Cardiff Oncology Inc’s current trading price is -21.62% away from its 52-week high, while its distance from the 52-week low is 119.90%. The stock’s price range for this period has been between $2.01 and $5.64. The Healthcare sector company’s shares saw a trading volume of about 1.92 million for the day, which was higher than the average daily volume of 1.13 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
Cardiff Oncology Inc (CRDF) has experienced a quarterly rise of 58.42% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 294.05M and boasts a workforce of 33 employees.
Expert Opinions: Analysts’ Ratings for Cardiff Oncology Inc
As of right now, 4 analysts are rating Cardiff Oncology Inc as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 3.38, with a change in price of -0.28. Similarly, Cardiff Oncology Inc recorded 1,220,018 in trading volume during the last 100 days, posting a change of -5.96%.
CRDF’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for CRDF stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
CRDF Stock Stochastic Average
As of today, the raw stochastic average of Cardiff Oncology Inc over the past 50 days is 96.15%. This is a increase compared to the raw stochastic average of the last 20 days, which was recorded at 94.81%. Additionally, the Stochastic %K and %D values for the company were 92.52% and 90.08%, respectively, over the past 20 days.
